Study and Careers

About the Role Our Prospect Research team plays a central role in unlocking new funding opportunities across the ICR's philanthropic income streams. It is responsible for delivering high quality, insightful prospect briefings and fundraising intelligence, which supports the ICR's fundraisers in their efforts to build meaningful relationships with philanthropic high net-worth individuals, trusts, foundations and corporates who have the interest and capacity to support the ICR's vital research. The post holder will play a key role in supporting the Development & Communications directorate to source, assess and validate new funding opportunities, maximise income secured across our philanthropic income streams and fundraising campaign, and grow our incredible donor community. The successful candidate will have experience of devising and successfully implementing targeted prospecting strategies. You will play a lead role in identifying philanthropic HNWIs and corporates with the capacity and inclination to support our work. The post holder will also be responsible for carrying out due diligence research and alerting fundraisers to reputational risks identified in support of the ICR's gift acceptance policy. You will work closely with the Head of Prospect Development to support fundraisers in maximising the success of our senior volunteer network through network mapping and expanding its ranks. In addition, the post holder will manage the Prospect Research Executive, providing development and mentoring support. What We Offer A supportive and collaborative working environment. Opportunities for professional development and career progression. Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Caroline Porter via telephone on 020 7153 5486 or email at [email protected].

Job Details The Cancer Research UK funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU) seek an experienced and highly motivated Principal Statistician to join their team of over 20 statisticians. We want to hear from you if you: Enjoy the challenge of designing efficient clinical trials and analysing complex datasets to answer clinical questions that will make a difference in patients’ lives Seek variety in your work and opportunities to apply your statistical knowledge across multiple therapeutic areas in oncology. Thrive on being part of a multi-disciplinary research team with like-minded statisticians. Are looking to develop your career within a dynamic and supportive academic environment at a leading cancer clinical trials unit. Key Requirements The successful applicant will be an experienced and highly motivated medical statistician interested in applying their statistical knowledge to the design and analysis of patient-centred clinical trials. They will have a post-graduate qualification in statistics. They should demonstrate a solid understanding of clinical trials and experience in applying statistical methods to real-world data. Effective oral and written communication skills, as well as enthusiasm for collaborating with others from diverse disciplines, are essential. Department/Directorate Information ICR-CTSU manages an exciting portfolio of national and international phase II and III cancer clinical trials and an expanding number of phase I trials. You will work as part of a multi-disciplinary team on the statistical design and development of new trials. You will conduct and oversee analysis of a number of clinical trials and/ or associated imaging or translational biomarker research studies across our portfolio. In your supporting statement please summarise how your research/managerial experience fits with the role. We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion about the role please contact Nuria Porta, email [email protected] This is an office based role. Requests for hybrid working (splitting time between our Sutton site and home) may be considered following successful completion of key training and only if the role allows. Flexible working options may be considered. Informal enquiries may be made by emailing [email protected]

Department/Directorate Information The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer. The Drug Development Unit, within the ICR and Royal Marsden, is a dedicated Clinical Trials Unit, with bespoke facilities to conduct early phase clinical trials. The Unit, led by Professor Johann de Bono, comprises of clinicians, scientists, data and study management staff, and focuses on providing a seamless conduit between pre-clinical drug discovery, proof of principle Phase-1 clinical trials and tumour specific evaluation of novel agents. The Unit undertakes both industry-sponsored and investigator-initiated trials of new anti-cancer drugs. The Unit is rapidly expanding and provides an excellent opportunity for the post holder to develop a variety of skillsets. Summary of Role We are looking for an enthusiastic and committed GCP Officer to work within the Drug Development Unit which undertakes early phase clinical trials of new anticancer drugs. We are a world class clinical trials unit based on a dedicated ward within the Royal Marsden Hospital, for the development of novel cancer therapeutics which we believe will improve the care of cancer patients. The post holder will play a major role in maintaining GCP compliance within the DDU. Key Requirements The post holder will hold a university degree in a scientific discipline or similar qualification. Be knowledgeable in ICH-GCP regulatory standards for the conduct of clinical trials and have experience of monitoring and pharmacovigilance of Phase I oncology clinical trials. The post holder will provide full support to maintain GCP compliance within the ICR laboratories (Cancer Biomarker Team, PK/PD Laboratories and DMPK labs), supporting Clinical trials run by the DDU and/or other Units where applicable. The post holder must be organised and able to plan work around a busy clinical unit. They should have excellent communication skills and interpersonal skills, in order to interact effectively with unit staff. Appointments will be up to one-year maternity cover. This post also benefits from generous annual leave entitlement and a pension. To apply for this post, please submit an online application including a supporting statement, detailing reasons why you are applying for the post and include your CV. We encourage all applicants to access the job pack attached for more detailed information regarding this role. Due to the high volumes of applications that we receive, we reserve the right to close the advert before the published closing date, once we have received a sufficient number of applications. Therefore, we advise that you to submit your application, as early as possible to avoid disappointment.

Under the guidance of Cancer Technology Catalyst team lead Dr Patrick Kierkegaard, we are seeking to recruit a Health Economist to pioneer evaluations at the CRUK Convergence Science Centre. Based in South Kensington, London, with travel to partner sites (The Royal Marsden NHS Foundation Trust, ICR Sutton, Imperial College Healthcare NHS Trust). The successful candidate will lead early-stage health economic modelling and health technology assessment (HTA) for cutting-edge oncology innovations, including precision drugs, diagnostics, treatments, clinical guidelines, and digital health technologies (DHTs). Department/Directorate Information The Cancer Research UK Convergence Science Centre (CSC) is a partnership between Imperial College London and The Institute of Cancer Research (ICR) with funding from Cancer Research UK. Convergence research is driven by a societal need and utilises a deep integration across disciplines. Professor Axel Behrens is the Scientific Director of the CRUK Convergence Science Centre. This position of Health Economist is integrated within our Cancer Technology Catalyst team (CTC). The CTC is an initiative designed to expedite the journey of promising cancer technologies from concept to clinical impact. Led by a diverse team of experts, the CTC is committed to unlocking the full potential of innovative solutions and addressing the challenges inherent in bringing them to patients. By harnessing a collaborative Team Science approach, the CTC works closely with Principal Investigators and their teams to develop comprehensive evidence packages that not only inform robust value propositions for cancer technologies, but also strategically position them for successful clinical integration. About you Please see the attached job description for essential skills and qualifications for this role, and further information. What we offer A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Patrick Kierkegaard via [email protected].